General Information of Disease (ID: DISXBEJO)

Disease Name Centronuclear myopathy
Synonyms myopathy, myotubular; myopathy, centronuclear; myotubular myopathy; CNM; centronuclear myopathy
Disease Class 8C72: Congenital myopathy
Definition Centronuclear myopathy (CNM) is an inherited neuromuscular disorder characterized by clinical features of a congenital myopathy and centrally placed nuclei on muscle biopsy.
Disease Hierarchy
DISLSK9G: Congenital myopathy
DISXBEJO: Centronuclear myopathy
ICD Code
ICD-11
ICD-11: 8C72.01
Disease Identifiers
MONDO ID
MONDO_0018947
UMLS CUI
C0175709
MedGen ID
104495
Orphanet ID
595
SNOMED CT ID
82077006

Drug-Interaction Atlas (DIA) of This Disease

Drug-Interaction Atlas (DIA)
This Disease is Treated as An Indication in 1 Clinical Trial Drug(s)
Drug Name Drug ID Highest Status Drug Type REF
IONIS-DNM2-2.5Rx DM5LM3O Phase 2 Antisense oligonucleotide [1]
------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA) of This Disease

Molecular Interaction Atlas (MIA)
This Disease Is Related to 2 DTT Molecule(s)
Gene Name DTT ID Evidence Level Mode of Inheritance REF
DMPK TTZQTY2 Strong Genetic Variation [2]
RYR1 TTU5CIX Strong Genetic Variation [3]
------------------------------------------------------------------------------------
This Disease Is Related to 13 DOT Molecule(s)
Gene Name DOT ID Evidence Level Mode of Inheritance REF
CCDC78 OTWZVF89 Limited Autosomal dominant [4]
MTMR12 OTH3V9L1 Limited Biomarker [5]
SPEG OTQXWJR4 Limited Genetic Variation [6]
MTMR14 OTUUEY6Q moderate Biomarker [7]
TTN OT0LZ058 moderate Genetic Variation [8]
AMPH OTWPGWZX Strong Biomarker [9]
CCNT2 OTBDRH1J Strong Altered Expression [10]
DES OTI09KBW Strong Genetic Variation [11]
ECEL1 OTJ6GNUP Strong Genetic Variation [12]
GMPPB OTJ0CCJ8 Strong Genetic Variation [13]
MTMR2 OTNCYGBP Strong Genetic Variation [9]
PLEK OTB73XXA Strong Genetic Variation [14]
BIN1 OTK8O0X8 Definitive Semidominant [4]
------------------------------------------------------------------------------------
⏷ Show the Full List of 13 DOT(s)

References

1 Clinical pipeline report, company report or official report of Ionis Pharmaceuticals.
2 Myotonia in DNM2-related centronuclear myopathy.J Neural Transm (Vienna). 2014 May;121(5):549-53. doi: 10.1007/s00702-013-1140-8. Epub 2013 Dec 24.
3 Quantitative RyR1 reduction and loss of calcium sensitivity of RyR1Q1970fsX16+A4329D cause cores and loss of muscle strength.Hum Mol Genet. 2019 Sep 15;28(18):2987-2999. doi: 10.1093/hmg/ddz092.
4 Technical standards for the interpretation and reporting of constitutional copy-number variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics (ACMG) and the Clinical Genome Resource (ClinGen). Genet Med. 2020 Feb;22(2):245-257. doi: 10.1038/s41436-019-0686-8. Epub 2019 Nov 6.
5 Loss of catalytically inactive lipid phosphatase myotubularin-related protein 12 impairs myotubularin stability and promotes centronuclear myopathy in zebrafish.PLoS Genet. 2013 Jun;9(6):e1003583. doi: 10.1371/journal.pgen.1003583. Epub 2013 Jun 20.
6 Novel SPEG variant cause centronuclear myopathy in China.J Clin Lab Anal. 2020 Feb;34(2):e23054. doi: 10.1002/jcla.23054. Epub 2019 Oct 18.
7 EDTP/MTMR14: A novel target for improved survivorship to prolonged anoxia and cellular protein aggregates.Neurosci Lett. 2019 Jul 13;705:151-158. doi: 10.1016/j.neulet.2019.04.053. Epub 2019 Apr 25.
8 Integrated allelic, transcriptional, and phenomic dissection of the cardiac effects of titin truncations in health and disease.Sci Transl Med. 2015 Jan 14;7(270):270ra6. doi: 10.1126/scitranslmed.3010134.
9 Amphiphysin 2 modulation rescues myotubular myopathy and prevents focal adhesion defects in mice.Sci Transl Med. 2019 Mar 20;11(484):eaav1866. doi: 10.1126/scitranslmed.aav1866.
10 Cyclin T2a gene maps on human chromosome 2q21.J Histochem Cytochem. 2001 Jun;49(6):693-8. doi: 10.1177/002215540104900603.
11 Clathrin plaques and associated actin anchor intermediate filaments in skeletal muscle.Mol Biol Cell. 2019 Mar 1;30(5):579-590. doi: 10.1091/mbc.E18-11-0718. Epub 2019 Jan 2.
12 ECEL1 mutation causes fetal arthrogryposis multiplex congenita.Am J Med Genet A. 2015 Apr;167A(4):731-43. doi: 10.1002/ajmg.a.37018. Epub 2015 Feb 23.
13 A homozygous mutation in GMPPB leads to centronuclear myopathy with combined pre- and postsynaptic defects of neuromuscular transmission.Neuromuscul Disord. 2019 Aug;29(8):614-617. doi: 10.1016/j.nmd.2019.07.001. Epub 2019 Jul 5.
14 Adult course in dynamin 2 dominant centronuclear myopathy with neonatal onset.Neuromuscul Disord. 2010 Jan;20(1):53-6. doi: 10.1016/j.nmd.2009.10.006. Epub 2009 Nov 22.